These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6447928)

  • 1. The destruction of factor VIII clotting activity by thrombin and plasmin.
    Denson KW; Redman CW
    Thromb Res; 1980 May 1-15; 18(3-4):547-9. PubMed ID: 6447928
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasmin-induced procoagulant effects in the blood coagulation: a crucial role of coagulation factors V and VIII.
    Ogiwara K; Nogami K; Nishiya K; Shima M
    Blood Coagul Fibrinolysis; 2010 Sep; 21(6):568-76. PubMed ID: 20625277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Blood coagulation studies during streptokinase, heparin and plasmin therapy].
    Perlick E; Conrad E; Zimmermann S; Müldner J; Bach H
    Z Gesamte Inn Med; 1968 Mar; 23(5):Suppl:80 c. PubMed ID: 4234981
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of leukocytes, plasmin and thrombin on clotting factors. A comparative in vitro study.
    Henriksson P; Nilsson IM
    Thromb Res; 1979; 16(3-4):301-12. PubMed ID: 160093
    [No Abstract]   [Full Text] [Related]  

  • 5. Thrombin potentiation of factor VIII procoagulant activity: assessment by the two-stage assay.
    Kopitsky RG; Switzer ME; McKee PA
    Thromb Haemost; 1982 Apr; 47(2):145-9. PubMed ID: 6213066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dissolution of human cross-linked plasma fibrin clots by the equimolar human plasmin-derived light (B) chain-streptokinase complex. The acceleration of clot lysis by pretreatment of fibrin clots with the light (B) chain.
    Summaria L; Boreisha IG; Arzadon L; Robbins KC
    Thromb Res; 1977 Sep; 11(3):377-89. PubMed ID: 144332
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo and in vitro effects of thrombin and plasmin on human factor VIII (AHF).
    Lian EC; Nunez RL; Harkness DR
    Am J Hematol; 1976; 1(4):481-91. PubMed ID: 137671
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of thrombin on the clotting activity of F VIII.
    Vukovich T; Koller E; Doleschel W
    Thromb Res; 1980 Apr 1-15; 18(1-2):297. PubMed ID: 6773182
    [No Abstract]   [Full Text] [Related]  

  • 10. Sensitivity and specificity of plasma serine protease chromogenic substrates.
    Bang NU; Mattler LE
    Haemostasis; 1978; 7(2-3):98-104. PubMed ID: 149051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of clotting as the result of plasminogen activation by streptokinase. 2. Analytical studies of the clotting mechanism.
    BELLER FK; GLAS P
    Thromb Diath Haemorrh; 1960 Jun; 4():520-33. PubMed ID: 13798543
    [No Abstract]   [Full Text] [Related]  

  • 12. [On the demonstration of plasmin deficiency in retracted clots of full blood and on its significance in the lysis with streptokinase].
    Gottlob R; Blümel G
    Thromb Diath Haemorrh; 1966 May; 15(3):570-90. PubMed ID: 5989036
    [No Abstract]   [Full Text] [Related]  

  • 13. Potentiation of the anti-factor VIII effect of thrombin in plasma by the plasminolytic derivatives of fibrinogen and fibrin.
    Chandra S; Triantaphyllopoulos DC
    Thromb Diath Haemorrh; 1973 Nov; 30(2):235-47. PubMed ID: 4272616
    [No Abstract]   [Full Text] [Related]  

  • 14. Anticoagulant and thrombolytic drugs. I. Patho-physiological and pharmacological aspects.
    Ogston D; Douglas AS
    Drugs; 1971; 1(3):228-46. PubMed ID: 4256645
    [No Abstract]   [Full Text] [Related]  

  • 15. [Blood coagulating properties of immobilized proteases].
    Zubairov DM; Zinkevich OD
    Vopr Med Khim; 1976; 22(2):187-91. PubMed ID: 140525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of plasmin, microplasmin, and streptokinase-plasmin complex for the in vitro degradation of fibronectin and laminin- implications for vitreoretinal surgery.
    Hermel M; Dailey W; Hartzer MK
    Curr Eye Res; 2010 May; 35(5):419-24. PubMed ID: 20450255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The evaluation of plasmin and streptokinase activator complexes in a new rabbit model of venous thrombosis.
    Dupe RJ; English PD; Smith RA; Green J
    Thromb Haemost; 1981 Aug; 46(2):528-34. PubMed ID: 6458112
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Parallel destruction of factor VIII procoagulant activity and an 85,000 dalton protein in highly purified factor VIII/VWF.
    Cockburn CG; de Beaufre-Apps RJ; Wilson J; Hardisty RM
    Thromb Res; 1981 Feb; 21(3):295-309. PubMed ID: 6454278
    [No Abstract]   [Full Text] [Related]  

  • 20. Degradation of bovine factor 8 by plasmin and trypsin.
    Kirby EP; Martin N; Marder VJ
    Blood; 1974 May; 43(5):629-40. PubMed ID: 4274479
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.